Journal of Hepatology
Volume 49, Issue 3 , Pages 329-338, September 2008

Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy☆

  • James R. Burton Jr.

      Affiliations

    • University of Colorado Denver, School of Medicine, Division Gastroenterology & Hepatology, Hepatitis C Research Center, Aurora, CO, USA
    • ,
  • Jared Klarquist

      Affiliations

    • University of Colorado Denver, School of Medicine, Division Gastroenterology & Hepatology, Hepatitis C Research Center, Aurora, CO, USA
    • ,
  • KyungAh Im

      Affiliations

    • University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, USA
    • ,
  • Sue Smyk-Pearson

      Affiliations

    • University of Colorado Denver, School of Medicine, Division Gastroenterology & Hepatology, Hepatitis C Research Center, Aurora, CO, USA
    • ,
  • Lucy Golden-Mason

      Affiliations

    • University of Colorado Denver, School of Medicine, Division Gastroenterology & Hepatology, Hepatitis C Research Center, Aurora, CO, USA
    • ,
  • Nicole Castelblanco

      Affiliations

    • University of Colorado Denver, School of Medicine, Division Gastroenterology & Hepatology, Hepatitis C Research Center, Aurora, CO, USA
    • ,
  • Norah Terrault

      Affiliations

    • University of California – San Francisco, Division of Gastroenterology and Hepatology, San Francisco, CA, USA
    • ,
  • Hugo R. Rosen

      Affiliations

    • University of Colorado Denver, School of Medicine, Division Gastroenterology & Hepatology, Hepatitis C Research Center, Aurora, CO, USA
    • Corresponding Author InformationCorresponding author. Present address: Waterman Professor of Medicine and Immunology, Division Head, Gastroenterology & Hepatology, GI & Hepatology Division, B-158 Academic Office Building 1, 12631 East 17th Avenue, Room 7614, P.O. Box 6511, Aurora, CO 80045, USA. Tel.: +1 303 724 1858; fax: +1 303 724 1891.
    • ,
  • for the Virahep-C Study Group

Received 28 December 2007; received in revised form 22 April 2008; accepted 7 May 2008. published online 25 June 2008.

Associate Editor: V. Barnaba

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Dr. Terrault receives honoraria and grant support from Roche Pharmaceuticals. No other authors have a potential conflict of interest to report . NIH funded study . This study was funded as a cooperative agreement by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) with co-support from the National Center on Minority Health and Health Disparities (NCMHD) and the Intramural Research Program of the National Cancer Institute (NCI) with further support under a Cooperative Research and Development Agreement (CRADA) with Roche Laboratories, Inc. Grant Nos: U01 DK60329, U01 DK60340, U01 DK 60324, U01 DK 60344, U01 DK60327, U01 DK 60335, U01 DK60352, U01DK 60342, U01 DK 60345, U01 DK 60309, U01 DK 60346, U01 DK 60349, U01 DK 60341. Other support: National Center for Research Resources (NCRR) General Clinical Research Centers Program Grants: M01 RR00645 (New York Presbyterian), M02 RR000079 (University of California, San Francisco), M01 RR 16500 (University of Maryland), M01 RR000042 (University of Michigan), M01 RR00046 (University of North Carolina).

PII: S0168-8278(08)00370-X

doi:10.1016/j.jhep.2008.05.020

Journal of Hepatology
Volume 49, Issue 3 , Pages 329-338, September 2008

Article Tools

* Image Usage & Resolution